by Yannis Natsis | Feb 24, 2021 | Universal Access and Affordable Medicines | Latest Developments
EPHA’s submission to the feedback mechanism on the on the HERA (Health Emergency Preparedness and Response Authority) inception impact assessment The COVID-19 pandemic has shown that Europe has paid the price of not being prepared in the biomedical research &...
by Matteo Barisione | Jan 18, 2021 | Clean Air | Latest Developments
As part of the European Green Deal, the EU plans to revise air quality standards with a legislative proposal by the end of 2022. In its response to the European Commission’s consultation on the revision of these rules, EPHA calls on the Commission to be bold...
by George Thurley | Jan 6, 2021 | Trade for health | Latest Developments
EPHA recently participated in a consultation process conducted by DG Trade, focusing on how the Commission department can improve how it reaches and listens to CSOs in Brussels and across the EU Member States. In answering the questions posed, a number of points...
by European Public Health Alliance | Dec 1, 2020 | Health Inequalities, Healthy Economic Policy | Latest Developments
The European Public Health Alliance welcomes the European Commission’s commitment to advance Europe’s social and economic development by proposing an action plan aiming to strengthen the implementation of the European Pillar of Social Rights.The unprecedented crisis...
by Yannis Natsis | Nov 14, 2020 | Universal Access and Affordable Medicines | Analysis & Opinion
We have come a long way in a short period of time since the adoption of the groundbreaking June 2016 Council Conclusions on pharmaceuticals. The conclusions were a milestone for the access to medicines debate as they signaled the political acknowledgment of the series...
